Rajangam Kanya 4
4 · Senti Biosciences, Inc. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Rajangam Kanya
Pres. & Chief Med. & Dev. Off.
Transactions
- Award
Common Stock
2024-02-01+101,000→ 101,000 total - Award
Stock Option (Right to Buy)
2024-02-01+152,000→ 152,000 totalExercise: $0.46Exp: 2034-01-31→ Common Stock (152,000 underlying)
Footnotes (2)
- [F1]The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date.
- [F2]The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date.